{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:02:19Z","timestamp":1789916539205,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.seizure.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:15:58Z","timestamp":1783120558000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early ketamine plus midazolam therapy and clinical outcomes in pediatric refractory convulsive status epilepticus: A retrospective cohort study"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-0943","authenticated-orcid":false,"given":"Merve","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-4360","authenticated-orcid":false,"given":"\u0130brahim","family":"Bing\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2026.07.004_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1175370","article-title":"Treatment of pediatric convulsive status epilepticus","volume":"14","author":"Becker","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2026.07.004_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(24)00430-7","article-title":"Diagnosis and management of status epilepticus: improving the status quo","volume":"24","author":"Gettings","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2026.07.004_bib0003","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus: report of the ILAE Task Force","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.07.004_bib0004","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/epi.18455","article-title":"Optimizing pediatric status epilepticus management: the role of early midazolam infusion and adherence to clinical practice guidelines","volume":"66","author":"Rosati","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.07.004_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/epi4.12707","article-title":"Epileptic status in a PEDiatric cohort (ESPED) requiring intensive care treatment: a multicenter, national, two-year prospective surveillance study","volume":"8","author":"Meyer","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2026.07.004_bib0006","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2147\/IJGM.S295855","article-title":"Epidemiology and outcomes of status epilepticus","volume":"Volume 14","author":"Ascoli","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.seizure.2026.07.004_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Fang","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.07.004_bib0008","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2026.07.004_bib0009","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for refractory status epilepticus: a systematic review","volume":"32","author":"Rosati","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2026.07.004_bib0010","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.07.004_bib0011","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yebeh.2015.06.019","article-title":"Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation","volume":"49","author":"Ilvento","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2026.07.004_bib0012","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0883073817698629","article-title":"Increasing ketamine use for refractory status epilepticus in US pediatric hospitals","volume":"32","author":"Keros","year":"2017","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2026.07.004_bib0013","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus","volume":"99","author":"Jacobwitz","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.07.004_bib0014","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/epi.18035","article-title":"Abu-Sawwa R. A systematic review and meta-analysis of ketamine in pediatric status epilepticus","volume":"65","author":"Chiriboga","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.07.004_bib0015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s12028-023-01859-2","article-title":"A comparison of ketamine and midazolam as first-line anesthetic infusions for pediatric status epilepticus","volume":"40","author":"Jacobwitz","year":"2024","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2026.07.004_bib0016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2025.03.011","article-title":"Combined ketamine and midazolam versus midazolam alone for initial treatment of pediatric generalized convulsive status epilepticus: a randomized controlled trial","volume":"167","author":"Othman","year":"2025","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2026.07.004_bib0017","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-3476(05)82544-2","article-title":"Assessing the outcome of pediatric intensive care","volume":"121","author":"Fiser","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.seizure.2026.07.004_bib0018","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: an updated pediatric risk of mortality score","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2026.07.004_bib0019","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: an update of the pediatric logistic organ dysfunction score","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2026.07.004_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness: a practical scale","volume":"304","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2026.07.004_bib0021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1528-1167.2009.02285.x","article-title":"Recommendation for a definition of acute symptomatic seizure","volume":"51","author":"Beghi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.07.004_bib0022","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2026.07.004_bib0023","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","article-title":"Time from convulsive status epilepticus onset to anticonvulsant administration in children","volume":"84","author":"S\u00e1nchez Fern\u00e1ndez","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.07.004_bib0024","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.07.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.122950","article-title":"Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions","volume":"459","author":"Kuki","year":"2024","journal-title":"J Neurol Sci"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:29:30Z","timestamp":1789914570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126001949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S1059131126001949"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.07.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early ketamine plus midazolam therapy and clinical outcomes in pediatric refractory convulsive status epilepticus: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}